Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

FTC Asks To Drop Par, Paddock From AndroGel Antitrust Row

FTC Asks To Drop Par, Paddock From AndroGel Antitrust Row

The Federal Trade Commission on Thursday sought to Drop Paddock Holdings and Endo subsidiary Par Pharmaceutical from a Georgia federal court case in which it alleges pharmaceutical companies illegally conspired to delay generic competition for AndroGel.



This post first appeared on Law360, please read the originial post: here

Share the post

FTC Asks To Drop Par, Paddock From AndroGel Antitrust Row

×

Subscribe to Law360

Get updates delivered right to your inbox!

Thank you for your subscription

×